OakChart

Anika Therapeutics Inc

ANIKHealthcare·Drug Manufacturers - Specialty & Generic·USA·Micro·NASD·Nov 11 • 3:59 PM ET

13.95+0.48 (3.56%)
2026-11-12 05:57 CET
Market cap
186.86 USD m
Revenue, TTM
123.43 USD m
Net income, TTM
-1.77 USD m
Free cash flow, TTM
2.29 USD m
EPS diluted, TTM
-0.14
P/E
-
Compare

Price

ANIK against its 20, 50 and 200-day averages
2050200beatmiss
15.0020.00181K363KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ANIKclose 13.9520-day 19.3250-day 19.96200-day 16.3813.9552w high

39.0% under the 52-week high of 22.88 on 10 Aug 2026. 52-week low 9.01 on 28 Jan 2026. Last 15 sessions, 63.9% high to low

Volume 1.14× normal · the line is the 50-bar volume average

Profile

ANIK
52-week range, 36% of the way up
9.0122.88

Anika Therapeutics, Inc. engages in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

IndexRUT
Employees235
IPOMay 03, 1993
Beta0.26
ATR, 14d1.23
Rel volume1.14
Short float2.58%
Insider own6.28%
Inst own91.79%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap186.86M
Enterprise Value168.05M
Income-1.77M
Sales123.43M
Book/sh10.27
Cash/sh3.36
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees235
IPOMay 03, 1993

Ratios

P/E-
Forward P/E13.95
PEG0.12
P/S1.51
P/B1.36
P/C4.16
P/FCF81.60
EV/EBITDA54.74
EV/Sales1.36
Quick Ratio2.72
Current Ratio3.86
Debt/Eq0.19
LT Debt/Eq0.18
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.14
EPS next Y1.00
EPS next Q0.13
EPS this Y909.09%
EPS next Y-9.91%
EPS next 5Y118.66%
EPS past 3/5Y9.40% 14.76%
Sales past 3/5Y-10.28% -2.86%
EPS Y/Y TTM94.37%
Sales Y/Y TTM9.42%
EPS Q/Q85.63%
Sales Q/Q9.98%
EarningsNov 06 BMO
EPS/Sales Surpr.-30.95% 3.94%

Ownership

Insider Own6.28%
Insider Trans0.24%
Inst Own91.79%
Inst Trans-1.53%
ROA-0.14%
ROE-0.18%
ROIC-1.09%
Gross Margin63.40%
Oper. Margin-2.11%
Profit Margin-1.43%
SMA20-27.81%
SMA50-30.12%
SMA200-14.81%
Trades-

Technical

Shs Outstand13.39M
Shs Float12.55M
Short Float2.58%
Short Ratio3.02
Short Interest0.32M
52W High22.88 -39.03%
52W Low9.01 54.83%
Volatility11.38% 5.97%
ATR (14)1.23
RSI (14)25.07
Beta0.26
Rel Volume1.14
Avg Volume107.11K
Volume122,530

Performance

Perf Week-31.62%
Perf Month-32.05%
Perf Quarter-34.10%
Perf Half Y-5.74%
Perf YTD45.16%
Perf Year37.71%
Perf 3Y-30.32%
Perf 5Y-63.48%
Perf 10Y-69.38%
Recom1.00
Target Price23.00
Prev Close13.47
Price13.95
Change %3.56%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 18, 2026ResumedRB. Riley SecuritiesBuy$23+64.9%
Apr 17, 2025InitiatedRB. Riley SecuritiesBuy$21+50.5%
Nov 01, 2024ReiteratedBBarrington ResearchOutperform$37 → $25+79.2%
Aug 14, 2023UpgradeBBarrington ResearchMkt Perform → Outperform$24+72.0%
Mar 07, 2023DowngradeBBarrington ResearchOutperform → Mkt Perform
Nov 09, 2022UpgradeBBarrington ResearchMkt Perform → Outperform$31+122.2%
Oct 14, 2022ResumedSStephensEqual-Weight$26+86.4%
Mar 09, 2022DowngradeSStephensOverweight → Equal-Weight$35+150.9%
Mar 09, 2022DowngradeBBarrington ResearchOutperform → Mkt Perform
Nov 16, 2021InitiatedSStephensOverweight$55+294.3%

Peers

Mkt cap
TickerCompanyMkt cap
BVSBioventus Inc926.03M
LFCRLifecore Biomedical Inc242.60M
PCRXPacira BioSciences Inc1.46B
VCELVericel Corp3.03B
ORGOOrganogenesis Holdings Inc136.29M
EOLSEvolus Inc491.11M
MDXGMimedx Group Inc484.47M
CNMDConmed Corp1.51B
ZBHZimmer Biomet Holdings Inc20.34B
SNNSmith & Nephew plc ADR12.99B

Insider trading

5 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Jellison William RFormer DirectorAug 07 '26Proposed Sale21.0716,864355,255Aug 07 05:28 PM
Fischetti Gary PDirectorAug 03 '26Buy20.751,00020,74553,015Aug 05 04:30 PM
Fischetti Gary PDirectorAug 04 '26Buy20.321,00020,31554,015Aug 05 04:30 PM
HENNEMAN JOHN B IIIDirectorMay 01 '26Buy14.665,00073,32054,871May 04 08:34 AM
Griffin Stephen D.President and CEOApr 30 '26Buy12.2912,200149,88136,163Apr 30 05:22 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
FSMDFidelity Small-Mid Multifactor ETFAUM: 2.48B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-060.2900.420-0.02030.5929.441
2026Q22026-07-290.4200.0300.24132.6129.211
2026Q12026-04-290.270-0.070-0.37429.6128.142
2025Q42026-02-260.310-0.1250.02030.6228.882
2025Q32025-11-050.040-0.180-0.16227.8227.802
2025Q22025-07-30-0.130-0.263-0.27628.2227.033
2025Q12025-05-09-0.060-0.090-0.34126.1728.073
2024Q42025-03-12-0.030-0.225-1.50030.6029.002
2024Q32024-10-31-0.2500.090-2.02638.7542.082
2024Q22024-08-080.1700.067-0.00641.9240.773
2024Q12024-05-080.090-0.080-0.30740.5239.143
2023Q42024-03-130.050-0.227-4.30142.9741.403
2023Q32023-11-020.000-0.353-0.44941.4738.273
2023Q22023-08-080.060-0.320-0.18744.3040.373
2023Q12023-05-09-0.360-0.340-0.70637.9237.363
2022Q42023-03-06-0.340-0.240-0.33539.6237.713

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY1.9601.9052.110113.42113.88
2018FY1.2701.0781.275105.56104.77
2019FY1.8902.0401.892114.61112.41
2020FY-1.690-0.685-1.686130.46131.28
2021FY0.2800.3970.283147.79144.03
2022FY-1.020-0.920-1.021156.24154.31
2023FY-0.300-0.913-5.641166.66165.1
2024FY0.1600.100-3.830119.91150.2
2025FY0.110-0.615-0.760112.82111.03
2026FY-1.110--121.58
2027FY-1.000--126.72
2028FY-1.150--134.45

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0620229.6729.6529.70
2026Q4S2026-09-1720129.9929.7030.29
2026Q4S2026-07-2920030.2930.2930.30
2026Q4S2026-07-1320030.4230.3030.55
2026Q4S2026-05-1221030.4230.3030.55
2026Q4S2026-04-2922030.4230.3030.55
2026Q4S2026-02-2622030.2229.9030.55
2026Q4S2025-11-1120029.7029.5029.89
2026Q4S2025-11-1020029.7029.5029.89
2026Q4S2025-11-0920029.7029.5029.89
2026Q4S2025-11-0820029.7029.5029.89
2026Q4S2025-11-0720029.7029.5029.89
2026Q4S2025-11-0620029.7029.5029.89
2026Q4R2026-11-062110.070.000.14

Estimate history

EPS, annual2.111.2751.892-1.6860.283-1.021-5.641-3.83-0.759-0.1357
Period201720182019202020212022202320242025TTM
EPS, quarterly-2.026-1.5-0.341-0.276-0.1620.02-0.3740.241-0.023
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual113.42105.555114.61130.457147.794156.236120.792119.907112.819123.43
Period201720182019202020212022202320242025TTM
Sales, quarterly38.75330.60226.16828.21927.81730.61529.61232.6130.594
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual14.68814.2114.30814.32914.44114.62514.6614.41613.88913.394
Period201720182019202020212022202320242025MRQ
Shares, quarterly14.69414.41614.33614.41814.42113.88913.35713.38313.394
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue123.43112.82119.91120.79156.24147.79130.46114.61105.56
Cost of Goods Sold Incl. D&A45.1749.0143.9138.2662.6664.8561.4328.7531.28
Gross Profit78.2663.8176.0082.5393.5882.9469.0385.8674.28
Selling, General and Administrative Excl. Other80.8674.8681.1081.69112.98100.8276.9551.2252.53
Research and Development28.4025.7725.5421.7628.1826.7322.0216.6618.19
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-2.60-11.05-5.100.84-19.40-17.88-7.9334.6521.75
Interest Expense0.000.000.000.000.00-0.800.000.00
Unusual Expense0.000.000.000.000.00-20.5020.390.40-
Net Income Before Taxes-1.00-9.31-2.763.16-18.752.43-28.6236.1223.21
Income Taxes-0.740.676.066.59-3.89-1.71-4.648.934.49
Consolidated Net Income-0.26-9.98-8.83-3.44-14.864.13-23.9827.1918.72
Net Income From Continuing Operations-0.26-9.98-8.83-3.44-14.864.13-23.9827.1918.72
Net Income-1.77-10.88-56.38-82.67-14.864.13-23.9827.1918.72
EPS (Recurring)-0.13-0.76-3.83-5.64-1.02-0.70-0.681.911.27
EPS (Basic, Before Extraordinaries)-0.13-0.76-3.83-5.64-1.020.29-1.691.931.30
EPS (Diluted)-0.14-0.76-3.83-5.64-1.020.28-1.691.891.27
EBITDA3.07-5.320.596.35-3.05-1.897.0741.8227.66
Non-Operating Income (Expense)1.601.742.342.310.65-0.190.501.871.46
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.758.079.6010.6911.318.095.194.448.73
Price To Earnings Ratio-----127.96-27.2726.06
Price To Sales Ratio2.131.222.022.752.763.554.936.504.68
Gross Margin63.4056.5663.3868.3359.8956.1252.9174.9270.37
Operating Margin-2.11-9.80-4.250.70-12.42-12.10-6.0830.2320.60
Net Margin-1.43-9.64-47.02-68.44-9.512.80-18.3823.7317.74
Shares Outstanding13.3913.8914.4214.6614.6214.4414.3314.3114.21
Market Capitalization186.86186.86241.07331.76432.45517.27643.35739.85477.63

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue30.5932.6129.6130.6127.8228.2226.1730.60
Cost of Goods Sold Incl. D&A11.7611.3710.6211.4412.2313.8611.4913.48
Gross Profit18.8421.2419.0019.1815.5814.3614.6817.12
Selling, General and Administrative Excl. Other19.5518.2924.4818.5318.8218.5418.9617.83
Research and Development7.897.346.716.456.956.316.066.51
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.712.95-5.490.65-3.23-4.18-4.28-0.71
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-0.323.38-4.820.76-2.24-3.97-3.870.04
Income Taxes-0.010.070.23-1.040.940.680.092.52
Consolidated Net Income-0.313.31-5.061.80-3.17-4.65-3.96-2.49
Net Income From Continuing Operations-0.313.31-5.061.80-3.17-4.65-3.96-2.49
Net Income-0.313.31-5.060.29-2.33-3.97-4.87-21.86
EPS (Recurring)-0.020.24-0.370.02-0.16-0.28-0.34-1.50
EPS (Basic, Before Extraordinaries)-0.020.25-0.370.02-0.16-0.28-0.34-1.50
EPS (Diluted)-0.020.24-0.370.02-0.16-0.28-0.34-1.50
EBITDA0.734.46-4.081.96-1.83-2.68-2.690.73
Non-Operating Income (Expense)0.390.430.670.121.000.210.410.74
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.351.450.011.941.752.012.371.78
Price To Sales Ratio2.131.661.691.251.201.231.561.58
Gross Margin61.5765.1564.1562.6556.0250.9056.1055.96
Operating Margin-2.339.06-18.532.11-11.62-14.81-16.37-2.31
Net Margin-1.0210.15-17.070.95-8.37-14.07-18.62-71.45
Shares Outstanding13.3913.3813.3613.8914.4214.4214.3414.42
Market Capitalization186.86194.66194.31138.59135.53151.73213.07241.07

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments57.4855.6368.7486.3394.3998.32184.94159.01157.26
Short Term Receivables23.6923.5926.3634.6329.8424.1023.0820.7723.82
Inventories18.7923.8124.4339.7736.0146.2122.0021.3022.04
Other Current Assets3.4010.6243.788.838.298.754.291.853.21
Total Current Assets103.36113.65163.31169.55168.53177.38234.31202.94206.33
Net Property, Plant & Equipment66.2664.6865.0078.9768.5673.2373.6554.1156.18
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable5.645.930.00------
Intangible Assets9.709.6210.1581.9490.1699.5715.2817.0418.85
Deferred Tax Assets13.4414.0616.311.4517.7715.6811.537.214.77
Other Assets4.037.6830.6917.2220.2915.427.484.901.25
Total Assets202.44215.63285.45349.13365.31381.29342.24286.20287.39
Short Term Debt Incl. Current Port. of LT Debt2.051.921.832.071.711.581.140.000.00
Accounts Payable6.045.626.199.077.638.983.833.146.75
Income Tax Payable0.000.061.240.81--0.000.39-
Other Current Liabilities13.8115.7121.8015.9620.4526.3011.307.766.33
Total Current Liabilities21.9123.3131.0627.9129.8036.8716.2811.2913.07
Long Term Debt24.2024.0125.9128.8219.2420.8821.370.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities12.1612.8914.826.4427.9327.5815.8610.7510.16
Other Liabilities0.701.431.390.401.2623.560.360.550.66
Total Liabilities58.9761.6473.1963.5678.22108.8953.8622.5923.89
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity143.47153.99212.26285.56287.08272.40288.38263.61263.49
Total Shareholders Equity143.47153.99212.26285.56287.08272.40288.38263.61263.49
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity143.47153.99212.26285.56287.08272.40288.38263.61263.49
Total Liabilities & Stockholders Equity202.44215.63285.45349.13365.31381.29342.24286.20287.39
Book Value Per Share10.3310.6814.4819.5319.8819.0120.1618.5517.94
Tangible Book Value Per Share9.6310.0113.7913.9213.6412.0619.0917.3516.66
Full-Time Employees235288357345297277154133123
Price to Book Ratio1.361.341.231.521.802.382.571.813.12
Return on Assets-4.77-3.52-1.08-4.161.11-6.638.656.5312.06
Return on Equity-6.71-4.82-1.38-5.191.48-8.559.857.1013.09
Return on Invested Capital-6.49-31.68-34.71-4.731.35-8.188.787.1012.07
Quick Ratio3.863.854.474.654.453.5613.0416.0914.10
Current Ratio4.724.885.266.075.664.8114.3917.9815.78

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-1.77-10.88-56.38-82.67-14.864.13-23.9827.1918.72
Depreciation5.675.738.1214.2216.3416.0214.997.175.91
Other Funds (Non Cash)21.0517.1766.5085.1120.024.7239.058.4915.30
Funds from Operations25.2512.0118.5010.3416.2323.1126.5243.6538.12
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-17.77-0.82-13.09-12.12-11.82-14.72-13.46-6.64-3.20
Income Taxes Payable1.29-0.130.670.531.44-1.31-2.07-1.080.92
Cash from Operating Activities7.4811.195.40-1.794.418.4013.0637.0134.92
Capital Expenditures-5.19-6.83-8.33-5.43-7.49-5.14-1.63-2.83-4.66
Net Assets From Acquisitions0.000.000.000.000.00-0.48-94.600.00-
Sale of Fixed Assets and Businesses0.004.500.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.002.5024.9642.52-45.60
Purchase of Investments0.000.000.000.000.000.00-20.04-103.85-91.60
Sale Or Maturity of Investments0.000.000.000.000.002.5045.00146.3746.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources1.111.930.000.000.000.000.000.000.00
Cash from Investing Activities-4.08-0.40-8.33-5.43-7.49-3.12-71.2639.69-50.26
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-14.61-8.98-10.13-4.170.681.131.52-7.85-27.11
Repurchase of Common Pref Stock-15.06-9.48-10.91-5.000.000.000.00-30.00-30.00
Sale of Common Pref Stock0.450.500.780.830.681.131.5222.152.89
Proceedsfrom Stock Options0.500.500.710.810.670.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.00-0.28-0.20-0.560.000.00
Change in Long Term Debt0.000.000.000.000.000.00-0.350.000.00
Issuance of Long Term Debt0.000.000.000.000.000.0050.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00-50.350.000.00
Net Financing Active Other Cash Flow-1.75-1.57-2.60-2.15-5.25-7.71-4.74-0.29-1.79
Other Financing Activities Uses-1.75-1.57-2.60-2.15-5.25-7.71-4.74-0.29-1.79
Cash from Financing Activities-16.35-10.55-12.73-6.32-4.85-6.78-3.77-8.14-28.90
Exchange Rate Effect-0.090.09-0.050.08-0.130.070.33-0.130.03
Net Change in Cash-13.030.32-15.71-13.46-8.06-1.43-61.6568.42-44.21
Free Cash Flow2.294.36-2.33-7.21-3.083.2511.4434.1830.26
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow114.6931.59---161.1456.2821.8116.31
Deferred Taxes & Investment Tax Credit--0.010.26-6.33-5.27-1.77-3.540.79-1.82

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments44.9638.4141.0257.4857.9953.17
Short Term Receivables24.2529.0625.7723.6922.1923.95
Inventories30.3528.5722.8418.7916.2816.92
Other Current Assets3.483.153.943.405.135.27
Total Current Assets103.0599.1993.56103.36101.5999.32
Net Property, Plant & Equipment66.5165.0565.1566.2664.9165.81
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets9.439.479.549.709.709.72
Deferred Tax Assets0.931.021.1513.441.251.25
Other Assets3.933.024.304.035.515.55
Total Assets189.60183.47179.39202.44189.44187.68
Short Term Debt Incl. Current Port. of LT Debt1.581.941.942.051.731.81
Accounts Payable6.036.246.346.044.734.77
Income Tax Payable---0.000.000.00
Other Current Liabilities19.1113.9812.6913.8112.639.49
Total Current Liabilities26.7322.1520.9721.9119.0916.08
Long Term Debt24.5723.3223.7924.2022.7823.17
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---12.16--
Other Liabilities0.730.730.730.700.760.76
Total Liabilities52.0246.1945.4958.9742.6340.01
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity137.58137.28133.90143.47146.81147.67
Total Shareholders Equity137.58137.28133.90143.47146.81147.67
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity137.58137.28133.90143.47146.81147.67
Total Liabilities & Stockholders Equity189.60183.47179.39202.44189.44187.68
Book Value Per Share10.2710.2610.0210.3310.1810.24
Tangible Book Value Per Share9.579.559.319.639.519.57
Full-Time Employees---235--
Price to Book Ratio1.361.461.400.940.921.02
Return on Assets-0.14-1.68-5.99-4.77-6.78-18.21
Return on Equity-0.18-2.19-7.85-6.71-8.73-22.91
Return on Invested Capital-0.192.06-3.210.17-1.37-2.32
Quick Ratio2.723.193.373.864.475.12
Current Ratio3.864.484.464.725.326.18

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.313.31-5.060.29-2.33-3.97
Depreciation0.512.431.411.321.401.42
Other Funds (Non Cash)6.352.637.884.183.386.20
Funds from Operations6.648.504.345.772.463.64
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.74-9.19-9.19-1.134.41-3.83
Income Taxes Payable-0.17-0.071.190.34-0.02-0.43
Cash from Operating Activities8.38-0.68-4.854.646.87-0.19
Capital Expenditures-1.66-1.45-1.43-0.65-1.89-1.47
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources-0.100.170.190.850.150.93
Cash from Investing Activities-1.76-1.28-1.240.20-1.73-0.54
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.00-0.64-8.69-5.280.000.26
Repurchase of Common Pref Stock0.00-0.85-8.69-5.510.000.00
Sale of Common Pref Stock0.000.210.000.240.000.26
Proceedsfrom Stock Options0.000.000.000.500.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.03-0.06-1.66-0.00-0.01-0.08
Other Financing Activities Uses-0.03-0.06-1.66-0.00-0.01-0.08
Cash from Financing Activities-0.03-0.70-10.35-5.28-0.010.18
Exchange Rate Effect-0.050.06-0.03-0.07-0.300.34
Net Change in Cash6.54-2.61-16.46-0.514.82-0.20
Free Cash Flow6.72-2.13-6.283.994.98-1.66
Price to Free Cash Flow114.69357.08188.8332.32209.16-

Revenue breakdown

Commercial Channel2024: 42.14M 2025: 48.41M
OEM Channel2024: 77.77M 2025: 64.41M
Europe2024: 19.40M 2025: 22.21M
Other Location2024: 18.06M 2025: 20.55M
United States2024: 82.45M 2025: 70.06M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.58%0.3M12.5M109.19K
2026-10-152.92%0.4M12.5M102.13K
2026-09-302.93%0.4M12.5M96.59K
2026-09-153.04%0.4M12.5M97.10K
2026-08-312.75%0.3M12.5M94.82K
2026-08-142.69%0.3M12.5M85.14K
2026-07-312.45%0.3M12.5M78.64K
2026-07-152.80%0.3M12.5M89.06K
2026-06-303.34%0.4M12.5M98.68K
2026-06-153.38%0.4M12.6M105.62K
2026-05-294.48%0.6M12.6M120.18K
2026-05-154.50%0.6M12.6M133.49K
2026-04-304.40%0.6M12.6M145.26K
2026-04-155.09%0.6M12.7M146.07K
2026-03-315.35%0.7M12.9M145.53K
2026-03-135.53%0.7M12.9M153.02K
2026-02-275.69%0.7M12.9M155.20K
2026-02-135.52%0.8M13.9M160.56K
2026-01-305.50%0.8M13.9M155.12K
2026-01-155.16%0.7M13.9M149.05K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.500.052.500.002.0440.000.000.682-0.1450.008
call15.000.003.000.001.6310.000.000.452-0.0870.009
call17.500.003.000.002.4410.000.000.343-0.1110.008
call20.000.003.002.303.0361.000.000.300-0.1300.008
call22.500.003.000.003.5140.000.000.275-0.1440.007
call25.000.003.000.003.9140.000.000.257-0.1550.007
call30.000.003.000.004.5620.000.000.235-0.1720.007
put12.500.002.000.003.2900.000.00-0.318-0.1440.008
put15.000.003.000.002.7480.000.00-0.548-0.0850.009
put17.502.105.200.003.2470.000.00-0.657-0.1090.008
put20.004.008.500.004.8200.000.00-0.700-0.1280.008
put22.506.5011.000.005.3410.000.00-0.725-0.1420.007
put25.009.0013.500.005.7780.000.00-0.743-0.1530.007
put30.0014.0018.400.006.3650.000.00-0.765-0.1690.007

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-068-KCurrent report2026-11-06SEC
2026-08-07144Filing for proposed sale of securities under Rule 144.SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-07-31SCHEDULE 13G/ASEC
2026-07-29S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-17SCHEDULE 13G/ASEC
2026-07-148-KCurrent report2026-07-10SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-238-KCurrent report2026-06-18SEC
2026-06-08DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-01DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-05-044Statement of changes in beneficial ownership of securities2026-05-01SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-30SEC
2026-04-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-29SCHEDULE 13GSEC
2026-04-298-KCurrent report2026-04-24SEC
2026-04-28ARSAnnual report to security holders. 2025-12-31SEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-18SEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-234Statement of changes in beneficial ownership of securities2026-03-19SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-14SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0841.06K200
2026-070000
2026-060000
2026-0573.32K100
2026-04149.88K100
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.10.90%
Caligan Partners LP10.79%
MORGAN STANLEY4.62%
ACADIAN ASSET MANAGEMENT LLC4.53%
VANGUARD CAPITAL MANAGEMENT LLC4.30%
AQR CAPITAL MANAGEMENT LLC4.21%
BOOTHBAY FUND MANAGEMENT, LLC3.98%
RENAISSANCE TECHNOLOGIES LLC3.62%
DIMENSIONAL FUND ADVISORS LP3.45%
GEODE CAPITAL MANAGEMENT, LLC3.13%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.99%
iShares Russell 2000 ETF2.34%
VANGUARD EXTENDED MARKET INDEX FUND1.22%
College Retirement Equities Fund - Total Global Stock Account1.07%
Fidelity Small Cap Index Fund0.92%
iShares Russell 2000 Value ETF0.79%
U.S. SMALL CAP VALUE PORTFOLIO0.65%
Schwab U.S. Small-Cap ETF0.50%
Fidelity Extended Market Index Fund0.49%
VANGUARD RUSSELL 2000 INDEX FUND0.49%

OakChart. ANIK. Cached 15 minutes.